Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...
INR:9521. bingo pescara lavora con noi Brilinta combined with aspirin significantly reduces the risk of acute ischemic stroke Shanghai Pharmaceutical ...
BIOX-101 is also in early development as a platform for a series of other indications, including ischemic stroke and other thrombo-inflammatory diseases. Bioxodes is a clinical stage biopharmaceutical ...